← Back to Search

Artificial Intelligence

Artificial Intelligence (AI) for Depression

N/A
Waitlist Available
Research Sponsored by Eleos Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be adults
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months before and 6 month after study start date
Awards & highlights

Study Summary

This trial aims to see if an AI platform can help case managers in a mental health and substance use disorder health system. They want to know if the AI platform is easy to use and if it helps

Who is the study for?
This trial is for case managers working in a nonprofit health system that deals with mental health and substance use disorders. They will be using an AI platform to manage around 250 adult clients. To participate, these case managers should be currently active and providing case management services.Check my eligibility
What is being tested?
The study is testing the impact of an AI platform on the productivity and satisfaction of case managers dealing with traumatic stress, depression, anxiety, and substance use disorders. It compares their performance before and after implementing this technology.See study design
What are the potential side effects?
Since this trial involves the use of an AI tool rather than a medical treatment, traditional side effects are not applicable. However, potential 'side effects' could include changes in workflow or job satisfaction among case managers.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months before and 6 month after study start date
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months before and 6 month after study start date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Case manager note completion time
Case manager productivity
Case manager satisfaction
Secondary outcome measures
Clients' crisis services utilization

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Artificial Intelligence (AI)Experimental Treatment1 Intervention
Once randomized to start using the AI-based platform for documenting their services, providers will have access to the Eleos Health platform, a secure and HIPAA-compliant tool specifically designed for documenting behavioral health encounters. This AI-powered platform enables providers to complete progress notes more quickly. Providers will complete the progress notes on their phones, and these notes will be integrated into the client's electronic health records.
Group II: Services-as-usual (SAU)Active Control1 Intervention
During the services-as-usual (SAU) phase of this study, providers will deliver the routine case management services offered by Centerstone and report these services in the usual way they do.

Find a Location

Who is running the clinical trial?

Centerstone Research InstituteOTHER
3 Previous Clinical Trials
1,512 Total Patients Enrolled
Eleos HealthLead Sponsor
1 Previous Clinical Trials
46 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the process of enrolling participants still ongoing for this medical study?

"Based on information provided by clinicaltrials.gov, this investigation is not in the process of seeking new participants. The trial was initially registered on February 19th, 2024 and last modified on February 25th, 2024. Despite no longer enrolling patients, there are currently a substantial number of active trials - precisely 1891 - that continue to recruit eligible individuals for participation."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
AI to Support Mental Health Case Management Providers
2024. "AI to Support Mental Health Case Management Providers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06280170.
All > Anxiety Disorder
~187 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top